期刊文献+

肺功能与慢性心力衰竭患者LVEF的关系 被引量:2

Relationship between pulmonary function and the LVEF of chronic heart failure patients
下载PDF
导出
摘要 目的 探讨肺功能与慢性心力衰竭患者LVEF的关系.方法 选择2008年1月-2010年5月在本院进行治疗的慢性心力衰竭患者101例,指标根据LVEF水平分为两组:EF下降组(EF值<50%)和EF正常组(EF值>50%).观察肺功能FVC、FEV1、FEV1%、FVC%及PEF%和TLCO-SB%在两组间的差异.结果 EF下降组肺功能的各项指标FVC、FEV1、FEV1%、FVC%及PEF%和TLCO-SB%分别为(1.39±0.7)、(1.10±0.5)、(66.2±11.9)、(66.5±17.8)、(61.2±16.9)、(61.4±16.2);EF正常组的分别为(1.95±0.7)、(1.50±0.5)、(79.2±10.4)、(76.5±15.1)、(73.5±14.0)、(72.4±12.0); EF下降组的各项肺功能指标均明显低于EF正常组,两组比较差异均有显著性(P<0.05).结论 肺功能与LVEF存在相关性,可考虑采用肺功能指标作为心功能衰竭的间接测定指标. Objective To investigate the correlation between pulmonary function and left ventricular ejection fraction(LVEF) in chronic heart failure(CHF) patients. Methods 101 patients from January 2008 to May 2010 in our hospital for heart failure treatment were chosen, and divided into two groups according to LVEF levels: EF decrease group (EF value of the "50%) and normal EF (EF values〉50%). Pulmonary function was observed FVC, FEV1, FEV 1%, FVC%, and PEF%, TLCO-SB% difference between the two groups. Results Compared with the EF value normal group, FVC, FEV1, FEV 1%,FVC% and PEF%, TLCO-SB% in EF value declined group had statistical significant difference (P〈0.05).Conclusion It has relationship between pulmonary function and LVEF of CHF patients. It can consider adopting lung function indexes as indirect indicators of heart failure indicators.
出处 《国际医药卫生导报》 2011年第8期921-924,共4页 International Medicine and Health Guidance News
关键词 肺功能 心力衰竭 射血分数 Pulmonary function Heart failure Ejection fraction
  • 相关文献

参考文献10

  • 1Deswal A.Diastolic dysfunction and diastolic heart failure:mechanisms and epidemiology[J].Curr Cardiol Rep,2005,7(3):178-183. 被引量:1
  • 2Davis B R,Kostis J B,Simpson L M,et al.Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial[J].Circulation,2008,118(22):2259-2267. 被引量:1
  • 3弓孟春,严晓伟.欧洲心脏病学会2008年版心力衰竭的诊断和治疗指南解读[J].中国实用内科杂志,2009,29(8):703-706. 被引量:29
  • 4Dickstein K,Cohen-Solal A,Filippatos G,et al.ESC guidelines for the diagnosis and treatment of acute and chronic heart failu 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)[J].Eur J Heart Fail,2008,10(10):933-989. 被引量:1
  • 5St.Paul,Adam KF,Lindenfeld JA,et al.HFSA 2006 comprehensive heart failure practice guideline[J].Journal of cardiac failure 2006,12(1):e1-e2. 被引量:1
  • 6Singh R,Choudhury M,Kapoor P M,et al.A randomized trial of anesthetic induction agents in patients with coronary artery disease and left ventricular dysfunc-tion[J].Ann Card Anaesth,2010,13(3):217-223. 被引量:1
  • 7Varela-Roman A,Gonzalez-Juanatey JR,Basante P,et al.Clinical characteristics and prognosis of hospitalised inpatients with heart failure and preserved or reduced left ventricular ejection fraction[J].Heart,2002,88(3):249-254. 被引量:1
  • 8Ayres ST.Ventilatory management in acute pulmonary edema[J].Am J Med,1973,54:558-570. 被引量:1
  • 9Giannelli,Ayres SM,Buehler ME.Effect of pulmonary blood flow upon lung mechanics[J].J Clin Invest,1967,46(10):1625-1642. 被引量:1
  • 10祖秀光,王凤飞,牛然明,王秉臣,杨新毅.肺功能参数对早期左心功能不全的诊断价值[J].中国心血管杂志,2000,5(2):83-84. 被引量:3

共引文献29

同被引文献10

  • 1Krum H, Teerlink JR. Medical therapy for chronic heart failure [J]. Lancet, 2011, 378(9792) 713-721. 被引量:1
  • 2Morrissey RP, Czer L, Shah PK. Chronic heart failure current evidence, challenges to therapy, and future di- rections [J]. Am J Cardiovasc I~rugs, 2011, 11(3): 153-171. 被引量:1
  • 3Pai JK, Curhan GC, Cannuscio CC, et al. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen col- lection [J]. Clin Chem, 2002, 48(10~ 1781-1784. 被引量:1
  • 4Prosen G, Klemen P, Strnad M, et al. Correctimt Com- bination of hmg ullrasound (a comet-tail sign) and N- terminal pro-brain natriuretic peptide in differentiating acute heart failure from chronic obstructive pulmonary disease and asthma as cause of acute dyspnea in prehospital emergency setting [J]. Crit Care, 2011, 15 (6) 450. 被引量:1
  • 5Dong X, Sumandea CA, Chen YC, et al. Augmented phosphorylation of cardiac troponin I in hypertensive heart failure [J]. J Biol Chem, 2012, 287(2): 848-857. 被引量:1
  • 6Gysen C, De Loof H, De Meyer G. Pharmaceutical care of heart failure theory and clinical practice [J]. J Pharm Belg, 2011,(3): 68-75. 被引量:1
  • 7Vasan RS, Sullivan LM, Roubenoff R, et al. Inflamma- tory markers and risk of heart failure in ehterly su])jeets without prior myocardial infarction: the Framingham Heart Study[J]. Circulation, 2003, 107(11):. 1486- 1491. 被引量:1
  • 8张健,张力,汪萍,张广慧,王连升.B型钠尿肽在冠心病严重程度及预后评估中的应用[J].检验医学,2011,26(6):372-374. 被引量:23
  • 9文红,欧雪珍,卫展扬,罗海波,张平,邓念强.慢性心功能不全住院患者治疗前后肺功能的改变[J].暨南大学学报(自然科学与医学版),2011,32(6):647-649. 被引量:3
  • 10王柏.慢性心功能衰竭治疗的新进展[J].中外医疗,2012,31(14):25-26. 被引量:1

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部